Sinopia Biosciences has a total of 33 patents globally, out of which 4 have been granted. Of these 33 patents, more than 90% patents are active. The US is where Sinopia Biosciences has filed the maximum number of patents, followed by China and Japan. Parallelly, the United States seems to be the main focused R&D center of Sinopia Biosciences and is also the origin country of the firm.
Sinopia Biosciences was founded in the year 2014 by Aarash Bordbar and Bernhard Palsson. The company enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Do read about some of the most popular patents of Sinopia Biosciences which have been covered by us in this article and also you can find Sinopia Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sinopia Biosciences patent portfolio.
How many patents does Sinopia Biosciences have?
Sinopia Biosciences has a total of 33 patents globally. These patents belong to 4 unique patent families. Out of 33 patents, 30 patents are active.
How Many Patents did Sinopia Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sinopia Biosciences Applications Filed | Sinopia Biosciences Patents Granted |
| 2022 | 4 | 2 |
| 2021 | 11 | – |
| 2020 | 6 | – |
| 2019 | 2 | 1 |
| 2018 | 1 | – |
| 2017 | 7 | – |
| 2016 | – | – |
| 2015 | – | – |
| 2014 | – | – |
| 2013 | – | – |
| 2012 | – | – |
| 2011 | – | – |
How many Sinopia Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sinopia Biosciences File in Different Countries?
Countries in which Sinopia Biosciences Filed Patents
| Country | Patents |
| United States Of America | 5 |
| China | 5 |
| Japan | 4 |
| Canada | 3 |
| Australia | 3 |
| Europe | 3 |
| Hong Kong (S.A.R.) | 2 |
| Singapore | 1 |
| Taiwan | 1 |
| Korea (South) | 1 |
| India | 1 |
| Israel | 1 |
Where are Research Centres of Sinopia Biosciences Patents Located?
The R&D Centre of patents filed by Sinopia Biosciences is in the US.
List of Sinopia Biosciences Patents
| Sinopia Biosciences Patents | Title |
| US11628170B2 | Treating Extrapyramtdal Syndrome Using Trapidil |
| US10350212B2 | Treating Extrapyramidal Syndrome Using Trapidil |
| US20230201205A1 | Treating Extrapyramidal Syndrome Using Trapidil |
| US20230102580A1 | Isotopically-Labelled Trapidil Derivatives |
| US20220378794A1 | Treating Cognitive Disorders Using Trapidil |
| EP4125853A1 | Isotopically-Labelled Trapidil Derivatives |
| EP4069239A1 | Treating Cognitive Disorders Using Trapidil |
| EP3442538A4 | Treating Extrapyramidal Syndrome Using Trapidil |
| CN116509869A | Treatment Of Extrapyramidal Syndrome With Trapidil |
| CN116496279A | Isotope-Labeled Trapidil Derivative |
| CN115916180A | Isotope-Labeled Trapidil Derivative |
| CN115397425A | Treatment Of Cognitive Disorders With Trapidil |
| CN109310700A | Treating Extrapyramidal Syndrome Using Trapidil |
| JP7049683B2 | Treatment Of Extrapyramidal Syndrome Using Trapidil |
| JP2023519289A | Isotope-Labeled Trapidil Derivatives |
| JP2023504004A | Treating Cognitive Impairment With Trapidil |
| JP2022088469A | Treatment Of Extrapyramidal Syndrome With Trapidil |
| AU2017246334C1 | Treating Extrapyramidal Syndrome Using Trapidil |
| CA3177066A1 | Isotopically-Labelled Trapidil Derivatives |
| CA3163242A1 | Treating Cognitive Disorders Using Trapidil |
| CA3054674A1 | Treating Extrapyramidal Syndrome Using Trapidil |
| AU2021244241A1 | Isotopically-Labelled Trapidil Derivatives |
| AU2020398858A1 | Treating Cognitive Disorders Using Trapidil |
| HK40088567A | Isotopically-Labelled Trapidil Derivatives |
| HK40004660A | Treating Extrapyramidal Syndrome Using Trapidil |
| IL296788A | Isotopically-Labelled Trapidil Derivatives |
| IN202217060920A | Isotopically-Labelled Trapidil Derivatives |
| KR1020230013023A | Isotopically Labeled Trapidyl Derivatives |
| SG11202253511VA | Isotopically-Labelled Trapidil Derivatives |
| TW202202502A | Isotopically-Labelled Trapidil Derivatives |
| WO2021195425A1 | Isotopically-Labelled Trapidil Derivatives |
| WO2021113266A1 | Treating Cognitive Disorders Using Trapidil |
| WO2017176652A3 | Treating Extrapyramidal Syndrome Using Trapidil |
What are Sinopia Biosciences’ key innovation segments?
What Technologies are Covered by Sinopia Biosciences?
The chart below distributes patents filed by Sinopia Biosciences